Japan
· Delayed Price · Currency is JPY Noile-Immune Biotech Statistics
Total Valuation
TYO:4893 has a market cap or net worth of JPY 6.15 billion. The enterprise value is 1.48 billion.
| Market Cap | 6.15B |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4893 has 43.30 million shares outstanding. The number of shares has increased by 4.41% in one year.
| Current Share Class | 43.30M |
| Shares Outstanding | 43.30M |
| Shares Change (YoY) | +4.41% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 39.49% |
| Owned by Institutions (%) | 1.23% |
| Float | 15.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 878.41 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.53 |
| EV / Sales | 211.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 69.20
| Current Ratio | 69.20 |
| Quick Ratio | 68.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.52% and return on invested capital (ROIC) is -12.84%.
| Return on Equity (ROE) | -18.52% |
| Return on Assets (ROA) | -12.63% |
| Return on Invested Capital (ROIC) | -12.84% |
| Return on Capital Employed (ROCE) | -22.60% |
| Revenue Per Employee | 280,000 |
| Profits Per Employee | -38.56M |
| Employee Count | 25 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 4.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.79% |
| 50-Day Moving Average | 154.98 |
| 200-Day Moving Average | 178.46 |
| Relative Strength Index (RSI) | 44.84 |
| Average Volume (20 Days) | 295,465 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4893 had revenue of JPY 7.00 million and -964.00 million in losses. Loss per share was -22.26.
| Revenue | 7.00M |
| Gross Profit | -61.00M |
| Operating Income | -1.07B |
| Pretax Income | -962.00M |
| Net Income | -964.00M |
| EBITDA | n/a |
| EBIT | -1.07B |
| Loss Per Share | -22.26 |
Balance Sheet
The company has 4.67 billion in cash and n/a in debt, giving a net cash position of 4.67 billion or 107.85 per share.
| Cash & Cash Equivalents | 4.67B |
| Total Debt | n/a |
| Net Cash | 4.67B |
| Net Cash Per Share | 107.85 |
| Equity (Book Value) | 4.72B |
| Book Value Per Share | 109.09 |
| Working Capital | 4.71B |
Cash Flow
| Operating Cash Flow | -887.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -15,271.43% |
| Pretax Margin | -13,742.86% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4893 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.41% |
| Shareholder Yield | -4.41% |
| Earnings Yield | -15.68% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TYO:4893 has an Altman Z-Score of 62.11.
| Altman Z-Score | 62.11 |
| Piotroski F-Score | n/a |